ThinkstockThe U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body. In its ruling, the court also ruled that synthetic molecules called complementary…
Paul Ausick Investors and traders are always searching for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great…
Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and…
ThinkstockMyriad Genetics Inc. (NASDAQ: MYGN) is seeing a benefit in its share price after actress Angelina Jolie wrote that a genetic test using Myriad’s gene sequencing tested positive for the gene with…
Jon C. Ogg ThinkstockIn theory, medical technology companies should be some of the market’s best-performing stocks. After all, it’s not really a cyclical business, and price tags are rarely a stumbling block when insurance companies,…
Investors and traders are always on the lookout for fresh Wall Street research ideas of stocks to buy, value stocks and dividend stocks. 24/7 Wall St. reviews many fresh research calls to…
ThinkstockShould a company get to patent your genetic DNA? That is the question when it comes to Myriad Genetics Inc. (NASDAQ: MYGN). This company and its stock are at the center of…
Jon C. Ogg The negative fourth-quarter gross domestic product (GDP) reading of -0.1% caught most Wall St. analysts and economists by surprise. This unforeseen number was skewed by a huge decrease in government spending. Most…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research notes this Wednesday. American Campus Communities Inc. (NYSE: ACC) raised to Buy at UBS. Anheuser-Busch…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Automatic Data Processing Inc. (NASDAQ: ADP) cut to Neutral at UBS. Bank…
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Avon Products Inc. (NYSE: AVP) Cut to Sell at UBS. Bank of America…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set…
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Adtran Inc. (NASDAQ: ADTN) Reiterated Buy and $39 target at Argus. Apple Inc. (NASDAQ:…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Altera Corporation (NASDAQ: ALTR) Cut to Neutral at Citigroup. Bank of America Corporation…
The pace of stock buyback announcements in the month of August was almost unbelievable. The pace was stronger at the start of the month when earnings were still coming in droves, but…
